Serum Lipoprotein (A) in Patients with Fibromyalgia Syndrome

Abstract

Background: Fibromyalgia syndrome (FMS) is the
most common rheumatic cause of diffuse pain and
multiple regional musculoskeletal pain and disability.
Objective: is to assess the contribution of serum
lipoprotein (A) in the pathogenesis of FMS patients.
Methods: One hundred twenty two FMS patients
were compared with 60 healthy control individuals
who were age and sex matched. All FMS features and
criteria are applied for patients and controls; patients
with secondary FMS were excluded. Serum
Lipoprotein (A): [Lp(A)], body mass index (BMI), &
s.lipid profile were determined for both groups.
Results: There was a statistical significant difference
between patients &controls in serum lipoprotein (A)
(P=0.013). Also there was a statistical significant
correlations between serum Lp(A) & FMS patients'
age( r= 0.310, P=0.034 ); but not with: duration(r= -
0.222, P=0.133) , BMI(r= 0.128,P=0.390) & s.lipid
profile ( p> 0.05) of FMS patients.
Conclusion: s.lipoprotein (A) may play an important
role in pathogenesis of FMS patients.